HGS-ETR1, a fully human agonistic monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) in patients with advanced solid cancer: Results of a phase 1 trial.

被引：0
|
作者：
Hirte, HW
Hotte, SJ
Chen, EX
Siu, L
Le, LH
Lo, L
MacLean, M
Iacobucci, A
Fox, NL
Oza, AM
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Juravinski Canc Ctr, Hamilton, ON, Canada
[3] Human Genome Sci Inc, Rockville, MD USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9104S / 9104S
页数：1
相关论文
共 50 条
  • [21] Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase 1 study in patients with advanced solid malignancies
    Mom, C. H.
    Sleijfer, S.
    Gietema, J. A.
    Fox, N. L.
    Piganeau, C.
    Lo, L.
    Uges, D. R. A.
    Loos, W.
    de Vries, E. G. E.
    Verweij, J.
    EJC SUPPLEMENTS, 2006, 4 (12): : 63 - 63
  • [22] Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1
    Tolcher, Anthony W.
    Mita, Monica
    Meropol, Neal J.
    von Mehren, Margaret
    Patnaik, Amita
    Padavic, Kristin
    Hill, Monique
    Mays, Theresa
    McCoy, Therese
    Fox, Norma Lynn
    Halpern, Wendy
    Corey, Alfred
    Cohen, Roger B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) : 1390 - 1395
  • [23] Human agonistic anti-TRAIL receptor antibodies, HGS-ETR1 and HGS-ETR2, induce apoptosis in diverse hematological tumor lines.
    Johnson, RL
    Huang, XL
    Fiscella, M
    Cole, C
    Pukac, L
    Von Kerczek, A
    Humphreys, R
    Grzegorzewski, KJ
    Gallant, G
    Albert, V
    BLOOD, 2003, 102 (11) : 891A - 891A
  • [24] HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo
    L Pukac
    P Kanakaraj
    R Humphreys
    R Alderson
    M Bloom
    C Sung
    T Riccobene
    R Johnson
    M Fiscella
    A Mahoney
    J Carrell
    E Boyd
    X T Yao
    L Zhang
    L Zhong
    A von Kerczek
    L Shepard
    T Vaughan
    B Edwards
    C Dobson
    T Salcedo
    V Albert
    British Journal of Cancer, 2005, 92 : 1430 - 1441
  • [25] In vitro synergistic anti-tumor activity by targeting TRAIL-R1 and CD20 antigen by combining HGS-ETR1 (agonistic human monoclonal antibody to TRAIL receptor 1) and rituximab monoclonal antibody against non-Hodgkin's lymphoma cells (NHL).
    Czuczman, MS
    Maddipatla, S
    Knight, J
    Hernandez-Ilizaliturri, FJ
    BLOOD, 2005, 106 (11) : 425A - 425A
  • [26] HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo
    Pukac, L
    Kanakaraj, P
    Humphreys, R
    Alderson, R
    Bloom, M
    Sung, C
    Riccobene, T
    Johnson, R
    Fiscella, M
    Mahoney, A
    Carrell, J
    Boyd, E
    Yao, XT
    Zhang, L
    Zhong, L
    von Kerczek, A
    Shepard, L
    Vaughan, T
    Edwards, B
    Dobson, C
    Salcedo, T
    Albert, V
    BRITISH JOURNAL OF CANCER, 2005, 92 (08) : 1430 - 1441
  • [27] A phase I and pharmacokinetic study of HGS-ETR1 (TRM-1), a human monoclonal agonist-anti body to TRAIL R1, in patients with advanced solid tumors
    Tolcher, AW
    Mita, M
    Patnaik, A
    Rowinsky, EK
    Corey, A
    Fleming, M
    Fox, NL
    Weiner, LM
    Meropol, NJ
    Cohen, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 210S - 210S
  • [28] Human agonistic antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 induces cytotoxicity and apoptosis in prostate cancer and bladder cancer cells
    Shimada, Osamu
    Wu, Xiuxian
    An, Xinghua
    Nouh, Mohammed Ahmed Abdel-Muneem
    Fiscella, Michele
    Albert, Vivian
    Matsuda, Tadashi
    Kakehi, Yoshiyuki
    UROLOGY, 2007, 69 (02) : 395 - 401
  • [29] Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes
    Lamhamedi-Cherradi, SE
    Zheng, SJ
    Tisch, RM
    Chen, YH
    DIABETES, 2003, 52 (09) : 2274 - 2278
  • [30] Expression of tumor necrosis factor-related apoptosis-inducing ligand receptors 1 and 2 in melanoma
    McCarthy, Mary M.
    Di Vito, Kyle A.
    Sznol, Mario
    Kovacs, Daniela
    Halaban, Ruth
    Berger, Aaron J.
    Flaherty, Keith T.
    Camp, Robert L.
    Lazova, Rossitza
    Rimm, David L.
    Kluger, Harriet M.
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3856 - 3863
12345